Biolom, INC.

About This Project

Produces revolutionary biosensors for diagnosis and monitoring of diseases.

Value Proposition

The company’s very small biosensor platform features four areas assembled with Antibody-Coated Nanoparticles (ACN), for the detection of proteins (biomarkers) or over-expression of the biomarkers in biological samples, e.g. blood, saliva, urine. The technology is up to 100 times more sensitive than competing technologies and is low cost, owing to the use of semiconductor manufacturing for fabrication of microchips.